Business · 27/01/1998
FDA Approves Guidant Corp.'s VENTAK AV AICD System
The US Food and Drug Administration (FDA) has granted premarket approval for Guidant Corp.'s VENTAK AV AICD System, an automatic implantable cardioverter defibrillator, following a successful application submitted by the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →